NURIX THERAPEUTICS, INC. (NRIX) Net margin 2019–2025
NURIX THERAPEUTICS, INC. (NRIX) net profit margin by fiscal year — reported net income divided by reported revenue.
-314.9%FY2025 · since FY2019: -69.7% → -314.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -314.9% | +39.9 pp |
| FY2024 | -354.9% | -167.9 pp |
| FY2023 | -187.0% | +280.0 pp |
| FY2022 | -466.9% | -73.0 pp |
| FY2021 | -393.9% | -151.3 pp |
| FY2020 | -242.7% | -172.9 pp |
| FY2019 | -69.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More NRIX financial trends
NRIX RevenueNRIX Net incomeNRIX Gross profitNRIX Gross marginNRIX Operating incomeNRIX Operating marginNRIX Operating cash flowNRIX Free cash flowNRIX Capital expendituresNRIX Return on equityNRIX Stock buybacksNRIX Dividends paidNRIX Total assetsNRIX Total liabilitiesNRIX Shareholders’ equityNRIX overview →